Renalytix Plc

OTCPK:RENX.F Stock Report

Market Cap: US$38.6m

Renalytix Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:RENX.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Dec 24BuyUS$3,065Fergus FlemingIndividual25,000US$0.12
10 Dec 24BuyUS$2,709James McCulloughIndividual25,000US$0.11
10 Dec 24BuyUS$2,492Julian BainesIndividual23,000US$0.11
10 Dec 24BuyUS$5,672Howard DoranIndividual50,000US$0.11
09 Dec 24BuyUS$5,116Howard DoranIndividual50,000US$0.10
05 Dec 24BuyUS$5,099James McCulloughIndividual53,300US$0.096
05 Dec 24BuyUS$4,340Christopher MillsIndividual48,601US$0.089
04 Dec 24BuyUS$2,211Julian BainesIndividual23,989US$0.092
01 Nov 24BuyUS$1,550,543Mount Sinai School Of Medicine, Endowment ArmCompany13,366,750US$0.12
07 Oct 24SellUS$8,761Harwood Capital LLPCompany83,696US$0.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RENX.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies555,5550.168%
Private Companies12,079,5153.65%
General Public15,994,5644.83%
Individual Insiders27,694,8728.36%
VC/PE Firms71,400,43421.6%
Institutions203,481,07261.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 99.6%.

Top Shareholders

Top 25 shareholders own 89.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.7%
Icahn School of Medicine at Mount Sinai
42,008,954US$4.9m0%2.71%
11.8%
Jefferson River Capital
39,050,434US$4.6m39.8%no data
9.77%
Heights Capital Management, Inc.
32,350,000US$3.8m-1.97%no data
8.6%
Ruffer LLP
28,500,000US$3.3m0%0.06%
7.79%
Unicorn Asset Management Ltd.
25,797,882US$3.0m36.1%0.42%
4.4%
Harwood Capital LLP
14,561,345US$1.7m0%0.13%
3.98%
Polar Capital Holdings Plc
13,196,197US$1.5m-51.6%no data
3.6%
Oberon Investments Group Plc
11,922,529US$1.4m0.26%0.62%
3.43%
Hamilton James
11,349,459US$1.3m0%no data
3.39%
JPMorgan Chase & Co.
11,231,151US$1.3m-0.12%no data
3.09%
Nathaniel Philip Victor Rothschild
10,232,522US$1.2m0%no data
3.03%
Pinnacle Associates, Ltd.
10,047,286US$1.2m0%0.02%
1.78%
Hargreaves Lansdown Asset Management Ltd.
5,893,172US$687.3k-4.31%no data
1.75%
Pentwater Capital Management LP
5,785,196US$674.7k0%0.02%
1.64%
First Equity Limited
5,417,000US$631.8k6.59%0.54%
1.44%
Aberdeen Group Plc
4,756,827US$554.8k3.44%no data
1.21%
NR Holdings Limited
4,001,187US$466.7k0%no data
1.21%
DB Capital Venture Partners
4,000,001US$466.5k0%100.0%
1.07%
Cooley LLP
3,541,666US$413.1k0%100.0%
0.95%
Qasf Capital Lp
3,132,832US$365.4k0%no data
0.77%
The Mccullough 2020 Irrevocable Trust
2,554,398US$297.9k0%no data
0.67%
FMR LLC
2,205,542US$257.2k0.57%no data
0.56%
Julian Baines
1,848,700US$215.6k0%no data
0.55%
Oliver Sterling
1,805,236US$210.5k0%no data
0.45%
Stockinvest Limited
1,501,145US$175.1k0.08%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/04 21:46
End of Day Share Price 2025/09/25 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Renalytix Plc is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anita DushyanthBerenberg
Mark MassaroBTIG
David WestenbergGuggenheim Securities, LLC